These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 16780279)
1. [Biological therapies of systemic lupus erythematosus]. Olesińska M; Chwalińska-Sadowska H; Mielnik P; Wiesik-Szewczyk E Pol Merkur Lekarski; 2006 Mar; 20(117):371-3. PubMed ID: 16780279 [TBL] [Abstract][Full Text] [Related]
2. New therapies for systemic lupus erythematosus. Strand V Rheum Dis Clin North Am; 2000 May; 26(2):389-406, viii. PubMed ID: 10768219 [TBL] [Abstract][Full Text] [Related]
3. Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Illei GG; Tackey E; Lapteva L; Lipsky PE Arthritis Rheum; 2004 Jul; 50(7):2048-65. PubMed ID: 15248202 [No Abstract] [Full Text] [Related]
5. Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events. Murdaca G; Colombo BM; Puppo F Autoimmun Rev; 2011 Nov; 11(1):56-60. PubMed ID: 21835271 [TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy of systemic lupus erythematosus. Francis L; Perl A Expert Opin Pharmacother; 2009 Jun; 10(9):1481-94. PubMed ID: 19505215 [TBL] [Abstract][Full Text] [Related]
7. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells. Grimaldi CM Curr Opin Rheumatol; 2006 Sep; 18(5):456-61. PubMed ID: 16896282 [TBL] [Abstract][Full Text] [Related]
8. Novel therapies in the treatment of systemic lupus erythematosus. Dequet CR; Wallace DJ Curr Opin Investig Drugs; 2001 Aug; 2(8):1045-53. PubMed ID: 11892912 [TBL] [Abstract][Full Text] [Related]
9. [Lupus erythematosus--a model of an autoimmune disease]. Sönnichsen N Dermatol Monatsschr; 1985; 171(8):481-92. PubMed ID: 3899754 [No Abstract] [Full Text] [Related]
10. Plasmapheresis in systemic lupus erythematosus: effects on cellular immunity. Vangelista A; Frascà GM; Nanni-Costa A; Bonomini V Trans Am Soc Artif Intern Organs; 1983; 29():749-53. PubMed ID: 6608818 [No Abstract] [Full Text] [Related]
11. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies. Lee HJ; Sinha AA Autoimmunity; 2006 Sep; 39(6):433-44. PubMed ID: 17060022 [TBL] [Abstract][Full Text] [Related]
14. Immunopathology and the gene therapy of lupus. Mageed RA; Prud'homme GJ Gene Ther; 2003 May; 10(10):861-74. PubMed ID: 12732872 [TBL] [Abstract][Full Text] [Related]
15. Development of biologicals for the therapy of lupus erythematosus. Neumann D; Tschernig T; Boraschi D Expert Rev Vaccines; 2007 Dec; 6(6):1001-11. PubMed ID: 18034656 [TBL] [Abstract][Full Text] [Related]
16. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives. Dejica DI; Manea EM Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113 [TBL] [Abstract][Full Text] [Related]
17. New therapies in systemic lupus erythematosus. Solsky MA; Wallace DJ Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):293-312. PubMed ID: 12041955 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls. Jacobi AM; Goldenberg DM; Hiepe F; Radbruch A; Burmester GR; Dörner T Ann Rheum Dis; 2008 Apr; 67(4):450-7. PubMed ID: 17673490 [TBL] [Abstract][Full Text] [Related]
19. Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus. Suciu-Foca N; Buda JA; Thiem T; Reemtsma K Clin Exp Immunol; 1974 Nov; 18(3):295-301. PubMed ID: 4283364 [TBL] [Abstract][Full Text] [Related]
20. Molecular aspects in the pathogenesis of human systemic lupus erythematosus. Liossis SN; Tsokos GC Arch Immunol Ther Exp (Warsz); 2000; 48(1):11-9. PubMed ID: 10722226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]